Skip to main content
. 2022 Sep 6;11(2):480–489. doi: 10.14218/JCTH.2022.00293

Fig. 1. Summary and comparison of the recommendations of TACE for HCC in different guidelines.

Fig. 1

BCLC, Barcelona Clinic Liver Cancer; CNLC, China liver cancer; cTACE, conventional transarterial chemoembolization; DEB-TACE, drug-eluting bead transarterial chemoembolization; ECOG, Eastern Cooperative Oncology Group; HCC, hepatocellular carcinoma; JSH, Japan Society of Hepatology; NCCN, National Comprehensive Cancer Network; PVTT, portal vein tumor thrombosis; TACE, transarterial chemoembolization.